NEW YORK, June 17 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today that a poster authored by NeoStem-affiliated scientists will be presented in a presentation at the premier stem cell research event, the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting in San Francisco on June 17, 2010.
Robin Smith, M.D., NeoStem's Chairman and Chief Executive Officer, said, "We are excited about this opportunity to present at the ISSCR conference, one of the most preeminent events in the world in stem cell research. We continue our efforts to advance the development and application of very small embryonic-like stem cells to treat regenerative diseases without the risk of serious graft versus host disease or tissue rejection typically associated with allogeneic stem cells. Our leading scientific research effort in the field is the subject of a multi-pronged collaboration with the Vatican's Pontifical Council for Culture to advance adult stem cell research."
ISSCR is an independent, nonprofit organization formed to foster the
exchange of information on stem cell research among the public, private,
academic and government arenas. The Annual Meeting provides a forum to promote
and foster the exchange of research, feature groundbreaking research from all
areas of stem cell science and serves as a catalyst for inspired stem cell
research around the world. The NeoStem study that shows the successful
|SOURCE NeoStem, Inc.|
Copyright©2010 PR Newswire.
All rights reserved